Cargando…

Role of Lubiprostone on Gastrointestinal Motility

Detalles Bibliográficos
Autor principal:	Jun, Jae Yeoul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Neurogastroenterology and Motility 2013
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714403/ https://www.ncbi.nlm.nih.gov/pubmed/23875092 http://dx.doi.org/10.5056/jnm.2013.19.3.277

Ejemplares similares

Effects of Lubiprostone on Pacemaker Activity of Interstitial Cells of Cajal from the Mouse Colon
por: Jiao, Han-Yi, et al.
Publicado: (2014)

Clubbed Digits Presumably Caused by Lubiprostone
por: Kawamoto, Ryuichi, et al.
Publicado: (2021)

Lubiprostone: a novel treatment for chronic constipation
por: Lacy, Brian E, et al.
Publicado: (2008)

Lubiprostone Stimulates Duodenal Bicarbonate Secretion in Rats
por: Mizumori, Misa, et al.
Publicado: (2009)

Lubiprostone stimulates small intestinal mucin release
por: De Lisle, Robert C
Publicado: (2012)

The Cost Effectiveness of Lubiprostone in Chronic Idiopathic Constipation
por: Pennington, Becky, et al.
Publicado: (2018)

The Important Roles of Interstitial Cells of Cajal and Cholinergic Receptors on Diabetes Related Dysfunction of Colon
por: Jun, Jae Yeoul
Publicado: (2011)

Lubiprostone ameliorates the cystic fibrosis mouse intestinal phenotype
por: De Lisle, Robert C, et al.
Publicado: (2010)

Diagnostics of Gastrointestinal Motility and Function: Update for Clinicians
por: Mari, Amir
Publicado: (2022)

A critical appraisal of lubiprostone in the treatment of chronic constipation in the elderly
por: Gras-Miralles, Beatriz, et al.
Publicado: (2013)

Lubiprostone for the Treatment of Adult Women with Irritable Bowel Syndrome with Constipation
por: Soubra, Mahmoud, et al.
Publicado: (2012)

Analysis of Nausea in Clinical Studies of Lubiprostone for the Treatment of Constipation Disorders
por: Cryer, Byron, et al.
Publicado: (2017)

Lubiprostone for the Treatment of Clozapine-Induced Constipation: A Case Series
por: Torrico, Tyler J, et al.
Publicado: (2022)

Factors associated with long-term efficacy of lubiprostone for chronic constipation
por: Morise, Takashi, et al.
Publicado: (2023)

The Excitatory Effect of Cholecystokinin on Colonic Motor Function via Cholecystokinin(1) Receptor
por: Jun, Jae Yeoul
Publicado: (2011)

Capsule and Sprinkle Formulations of Lubiprostone Are Not Biologically Similar in Patients with Functional Constipation
por: Adams, Atoya, et al.
Publicado: (2021)

Intrinsic Gastrointestinal Macrophages: Their Phenotype and Role in Gastrointestinal Motility
por: Cipriani, Gianluca, et al.
Publicado: (2016)

The Roles of Motilin and Ghrelin in Gastrointestinal Motility
por: Ohno, Tetsuro, et al.
Publicado: (2010)

A Randomized Study of Lubiprostone for Opioid-Induced Constipation in Patients with Chronic Noncancer Pain
por: Cryer, Byron, et al.
Publicado: (2014)

Possible Effect of Concomitant Prokinetics and Herbal Medicines against Nausea in Patients Taking Lubiprostone
por: Yamamoto, Takatsugu, et al.
Publicado: (2017)

Effects of Lubiprostone, an Intestinal Secretagogue, on Electrolyte Homeostasis in Chronic Idiopathic and Opioid-induced Constipation
por: Rao, Satish S.C., et al.
Publicado: (2021)

Safety of Lubiprostone in Pediatric Patients With Functional Constipation: A Nonrandomized, Open-Label Trial
por: Hussain, Sunny Z., et al.
Publicado: (2021)

Therapeutic role of Wuda granule in gastrointestinal motility disorder through promoting gastrointestinal motility and decreasing inflammatory level
por: Jiang, Zhi, et al.
Publicado: (2023)

Lubiprostone: evaluation of the newest medication for the treatment of adult women with constipation-predominant irritable bowel syndrome
por: Lunsford, Tisha N, et al.
Publicado: (2010)

A comparison of linaclotide and lubiprostone dosing regimens on ion transport responses in human colonic mucosa
por: Kang, Sang Bum, et al.
Publicado: (2015)

A Randomized, Placebo-Controlled Trial of Lubiprostone for Opioid-Induced Constipation in Chronic Noncancer Pain
por: Jamal, M Mazen, et al.
Publicado: (2015)

Effects of baseline abdominal pain and bloating on response to lubiprostone in patients with irritable bowel syndrome with constipation
por: Chang, L., et al.
Publicado: (2016)

Pharmacotherapy patterns in patients with chronic idiopathic constipation beginning treatment with linaclotide or lubiprostone in the United States
por: Nag, Arpita, et al.
Publicado: (2020)

A meta-analysis of randomized controlled trials of the addition of lubiprostone to bowel preparation before colonoscopy
por: Li, Peng, et al.
Publicado: (2020)

Effectiveness and safety of lubiprostone after switching from stimulant laxatives in elderly patients with chronic constipation
por: Maruyama, Masaki, et al.
Publicado: (2023)

The Role of Inflammatory Mediators in the Development of Gastrointestinal Motility Disorders
por: Docsa, Tibor, et al.
Publicado: (2022)

Role of Endoscopy in Motility Disorders of Upper Gastrointestinal Tract
por: Noh, Jin Hee, et al.
Publicado: (2023)

Lubiprostone in the treatment of chronic idiopathic constipation: an update on health-related quality of life and patient-reported outcomes
por: Hayat, Maham, et al.
Publicado: (2019)

Negative chronotropic and inotropic effects of lubiprostone on iPS cell-derived cardiomyocytes via activation of CFTR
por: Akita, Hiraku, et al.
Publicado: (2020)

An Illustrated Guide to Gastrointestinal Motility
por: Chen, May C.
Publicado: (1989)

Rimonabant, Gastrointestinal Motility and Obesity
por: Sun, Yan, et al.
Publicado: (2012)

Effects of gastrointestinal motility on obesity
por: Fu, Xiao-Yi, et al.
Publicado: (2014)

Methanogens, Methane and Gastrointestinal Motility
por: Triantafyllou, Konstantinos, et al.
Publicado: (2014)

Grape seed powder increases gastrointestinal motility
por: Choi, Na Ri, et al.
Publicado: (2022)

Role of gut microbiota-derived signals in the regulation of gastrointestinal motility
por: Zheng, Zhipeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gp5556079kf1bp6b900fecmbge